Targeting cellular heterogeneity with CXCR2 blockade for the treatment of therapy-resistant prostate cancer
published in: Science Translational Medicine
date of publication: 2019-12-01
Cites articles 1
Date
Title
Article - wd:Q91697568
Article - wd:Q91697568